Search research articles
Contact Us
Filters
Showing results (301-310 of 357) with videos related to
Page
of 36
Sort By:
American Journal of Hematology
|
June 26, 2019
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib
Fevzi Yalniz, Iman Abou Dalle, Hagop Kantarjian, et al.
Hepatology (Baltimore, Md.)
|
June 10, 2022
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH
Jun Xu, Ya Wang, Mina Khoshdeli, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
Gut
|
August 30, 2011
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
Alexander J Thompson, Keyur Patel, Wan-Long Chuang, et al.
Blood Advances
|
March 24, 2019
<i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.
Gastroenterology
|
July 20, 2010
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice
Hans L Tillmann, Alex J Thompson, Keyur Patel, et al.
American Journal of Hematology
|
December 23, 2016
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor
Nicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 2, 2023
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Lesley A Patmore, Warshan K Katwaroe, Daniel van der Spek, et al.
Spine
|
July 17, 2025
Does the Presence of Preoperative Myelomalacia Impact Outcomes Following ACDF?
Robert J Oris, Jonathan Dalton, Ryan Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis B
Lisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 357) with videos related to
Sort By:
Page
of 36
American Journal of Hematology
|
June 26, 2019
Prognostic significance of baseline FLT3-ITD mutant allele level in acute myeloid leukemia treated with intensive chemotherapy with/without sorafenib
Fevzi Yalniz, Iman Abou Dalle, Hagop Kantarjian, et al.
Hepatology (Baltimore, Md.)
|
June 10, 2022
IL-31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH
Jun Xu, Ya Wang, Mina Khoshdeli, et al.
Canadian Liver Journal
|
August 22, 2022
The Z-Profile Study: a multicenter, retrospective cohort study to assess the real-world use and effectiveness of elbasvir/grazoprevir in Canadian adult patients with chronic hepatitis C
Edward Tam, Julie Tremblay, Chris Fraser, et al.
Gut
|
August 30, 2011
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
Alexander J Thompson, Keyur Patel, Wan-Long Chuang, et al.
Blood Advances
|
March 24, 2019
<i>NPM1</i> mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy
Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, Koji Sasaki, et al.
Gastroenterology
|
July 20, 2010
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice
Hans L Tillmann, Alex J Thompson, Keyur Patel, et al.
American Journal of Hematology
|
December 23, 2016
Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor
Nicholas J Short, Hagop M Kantarjian, Koji Sasaki, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 2, 2023
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Lesley A Patmore, Warshan K Katwaroe, Daniel van der Spek, et al.
Spine
|
July 17, 2025
Does the Presence of Preoperative Myelomalacia Impact Outcomes Following ACDF?
Robert J Oris, Jonathan Dalton, Ryan Lin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis B
Lisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Page
of 36